Showing results (61-70 of 649) with videos related to
Sort By:
Pageof 65
Gut|December 1, 1977
Changes in the plasma clearance and protein binding of carbenoxolone with age, and their possible relationship with adverse drug effectsM J Hayes, M Sprackling, M J LangmanTherapeutic Drug Monitoring|July 17, 2014
High-throughput method for the quantification of lacosamide in serum using ultrafast SPE-MS/MSEric Korman, Loralie J Langman, Paul J JannettoBritish Medical Journal|January 3, 1976
Hospital admissions for peptic ulcer during 1958-72R C Brown, M J Langman, P M LambertClinical Biochemistry|December 7, 2019
The challenge that chlorine presented during the development of a benzodiazepine assayRichard G Lahr, Paul J Jannetto, Loralie J LangmanJournal of Analytical Toxicology|August 12, 2003
Fatal acute topiramate toxicityLoralie J Langman, Henry A Kaliciak, Sharon A BooneCancer Research|February 1, 1996
Antiproliferative responses to two human colon cancer cell lines to vitamin D3 are differently modified by 9-cis-retinoic acidK F Kane, M J Langman, G R WilliamsJournal of the American Academy of Dermatology|August 14, 2012
Therapeutic dose monitoring of mycophenolate mofetil in dermatologic diseasesOlayemi Sokumbi, Rokea A el-Azhary, Loralie J LangmanBritish Medical Journal|July 14, 1973
Treatment of chronic gastric ulcer with carbenoxolone and gefarnate: a comparative trialM J Langman, D R Knapp, E J WakleyClinical Chemistry|June 1, 1993
Cross-reactivities of cyclosporin G (NVa2 cyclosporin) and metabolites in cyclosporin A immunoassaysR W Yatscoff, L J Langman, D F LeGattBritish Journal of Clinical Pharmacology|February 1, 1975
Changes in drug metabolism with increasing age: 1. warfarin binding and plasma proteinsM J Hayes, M J Langman, A H ShortPageof 65